Compare Citius Pharmaceuticals Inc (CTXR) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Schwab US Dividend Equity ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.53 (market cap $14.64M), while Schwab US Dividend Equity ETF trades at $32.2. The key difference: Schwab US Dividend Equity ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | SCHD | |
|---|---|---|
Market Cap | $14.64M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.82 | $32.83 |
52-Week Low | $0.53 | $26.38 |
Enterprise Value | $10.86M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHD trades at $32.56, up 0.49% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF has recently underperformed the S&P 500 but shows strength in dividend-focused holdings, with nearly 30 components doubling the index's YTD return. A dividend of $0.25 is scheduled for June 2026, reinforcing its income appeal amid sideways price action since May.
Outlook remains favorable for income investors due to SCHD's high yield and dividend growth history, though competition from rising Treasury yields presents a risk. The ETF's low fee and quality stock selection support long-term wealth building, but market rotation away from value stocks could limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
